These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9473659)

  • 1. Effects of NMDA receptor glycine recognition site antagonism on cerebral metabolic rate for glucose and cerebral blood flow in the conscious rat.
    Morimoto Y; Wu B; Bart RD; Morimoto Y; Pearlstein RD; Warner DS
    Brain Res; 1998 Jan; 779(1-2):170-6. PubMed ID: 9473659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycine receptor antagonism. Effects of ACEA-1021 on the minimum alveolar concentration for halothane in the rat.
    McFarlane C; Warner DS; Nader A; Dexter F
    Anesthesiology; 1995 Apr; 82(4):963-8. PubMed ID: 7717569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective effects of NMDA receptor glycine recognition site antagonism: dependence on glycine concentration.
    Pearlstein RD; Beirne JP; Massey GW; Warner DS
    J Neurochem; 1998 May; 70(5):2012-9. PubMed ID: 9572287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N-methyl-D-aspartate (NMDA) receptor glycine site antagonist ACEA 1021 does not produce pathological changes in rat brain.
    Hawkinson JE; Huber KR; Sahota PS; Han Hsu H; Weber E; Whitehouse MJ
    Brain Res; 1997 Jan; 744(2):227-34. PubMed ID: 9027382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of glycine receptor antagonism on spreading depression in the rat.
    Martin H; Warner DS; Todd MM
    Neurosci Lett; 1994 Oct; 180(2):285-9. PubMed ID: 7700595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of glycine site NMDA receptor antagonists to protect against L-2-chloropropionic acid-induced neurotoxicity highlights the uniqueness of cerebellar NMDA receptors.
    Widdowson PS; Gyte AJ; Upton R; Wyatt I
    Brain Res; 1996 Nov; 738(2):236-42. PubMed ID: 8955518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycine antagonism does not block ischemic spontaneous depolarization in the rat.
    Takaoka S; Bart RD; Pearlstein RD; Warner DS
    Neuroreport; 1997 Mar; 8(5):1139-42. PubMed ID: 9175101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo models of cerebral ischemia: effects of parenterally administered NMDA receptor glycine site antagonists.
    Warner DS; Martin H; Ludwig P; McAllister A; Keana JF; Weber E
    J Cereb Blood Flow Metab; 1995 Mar; 15(2):188-96. PubMed ID: 7860652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACEA 1021, a glycine site antagonist with minor psychotomimetic and amnestic effects in rats.
    Kretschmer BD; Kratzer U; Breithecker K; Koch M
    Eur J Pharmacol; 1997 Jul; 331(2-3):109-16. PubMed ID: 9274968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective effect of NMDA receptor glycine recognition site antagonism persists when brain temperature is controlled.
    Takaoka S; Bart RD; Pearlstein R; Brinkhous A; Warner DS
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):161-7. PubMed ID: 9040495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
    Priestley T; Marshall GR; Hill RG; Kemp JA
    Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycine/NMDA receptor antagonists as potential CNS therapeutic agents: ACEA-1021 and related compounds.
    Cai SX
    Curr Top Med Chem; 2006; 6(7):651-62. PubMed ID: 16719807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites.
    Woodward RM; Huettner JE; Guastella J; Keana JF; Weber E
    Mol Pharmacol; 1995 Mar; 47(3):568-81. PubMed ID: 7700254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the novel high-affinity glycine-site N-methyl-D-aspartate antagonist ACEA-1021 on 125I-MK-801 binding after subdural hematoma in the rat: an in vivo autoradiographic study.
    Di X; Bullock R
    J Neurosurg; 1996 Oct; 85(4):655-61. PubMed ID: 8814170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACEA-1328, a NMDA receptor/glycine site antagonist, acutely potentiates antinociception and chronically attenuates tolerance induced by morphine.
    Lutfy K; Doan P; Weber E
    Pharmacol Res; 1999 Nov; 40(5):435-42. PubMed ID: 10527659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction among NMDA receptor-, NMDA glycine site- and AMPA receptor antagonists in spinally mediated analgesia.
    Nishiyama T
    Can J Anaesth; 2000 Jul; 47(7):693-8. PubMed ID: 10930211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of morphine tolerance by NMDA receptor antagonists in the formalin test.
    Lutfy K; Shen KZ; Woodward RM; Weber E
    Brain Res; 1996 Aug; 731(1-2):171-81. PubMed ID: 8883867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo antagonistic activities of SM-31900 for the NMDA receptor glycine-binding site.
    Ohtani K; Tanaka H; Yoneda Y; Yasuda H; Ito A; Nagata R; Nakamura M
    Brain Res; 2002 Jul; 944(1-2):165-73. PubMed ID: 12106676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Competitive inhibition at the glycine site of the N-methyl-D-aspartate receptor mediates xenon neuroprotection against hypoxia-ischemia.
    Banks P; Franks NP; Dickinson R
    Anesthesiology; 2010 Mar; 112(3):614-22. PubMed ID: 20124979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of glycine site antagonists of the NMDA receptor in global cerebral ischaemia.
    Hicks CA; Ward MA; Ragumoorthy N; Ambler SJ; Dell CP; Dobson D; O'Neill MJ
    Brain Res; 1999 Feb; 819(1-2):65-74. PubMed ID: 10082862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.